BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1087446)

  • 1. Surface cell markers in human lymphoid malignancies.
    Seligmann M; Preud'homme JL; Brouet JC
    Recent Results Cancer Res; 1976; (56):91-7. PubMed ID: 1087446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surface markers of lymphocytes in lymphoproliferative diseases].
    Burchardt K
    Pol Arch Med Wewn; 1976 Dec; 56(6):579-83. PubMed ID: 826893
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular differentiation markers in lymphoproliferative diseases.
    Siegal FP
    Hosp Pract; 1978 Oct; 13(10):79-89. PubMed ID: 310413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical patterns in B lymphoid malignancy.
    Galton DA; MacLennan IC
    Clin Haematol; 1982 Oct; 11(3):561-87. PubMed ID: 6756734
    [No Abstract]   [Full Text] [Related]  

  • 5. 2. Lymphocyte surface marker studies in lymphoma and leukemia.
    Lowenthal RM
    Pathology; 1982 Jul; 14(3):283-9. PubMed ID: 6752833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology.
    Koziner B; Filippa DA; Mertelsmann R; Gupta S; Clarkson B; Good RA; Siegal FP
    Am J Med; 1977 Oct; 63(4):556-67. PubMed ID: 303053
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Membrane markers in lymphoproliferative disorders.
    Lancet; 1975 Mar; 1(7908):670-1. PubMed ID: 47088
    [No Abstract]   [Full Text] [Related]  

  • 8. Surface markers define human lymphoid malignancies with differing prognoses.
    Kersey J; Coccia P; Bloomfield C; Nesbit M; McKenna R; Brunning R; Hallgren H; Gajl-Peczalska K
    Haematol Blood Transfus; 1977; 20():17-24. PubMed ID: 305392
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.
    Mann RB; Jaffe ES; Berard CW
    Am J Pathol; 1979 Jan; 94(1):105-92. PubMed ID: 367172
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-pathological study on malignant lymphomas and lymphatic leukemias from the view-point of T-cell and B-cell markers: Introduction (author's transl)].
    Tanaka N
    Rinsho Byori; 1978; 26(3):183-7. PubMed ID: 306457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proliferative syndromes of the B-lymphocyte system. The so-called double-shock hypothesis].
    Burghart-Czaplinska M
    Pol Tyg Lek; 1977 Apr; 32(15):575-7. PubMed ID: 404631
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignancies of the immune system.
    Virella G; Goust JM
    Immunol Ser; 1993; 58():517-41. PubMed ID: 8424992
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunofluorometric analyses of membrane bound IgM in individual human lymphoid cells in cases of leukemia and malignant lymphoma.
    Killander D; Johansson B; Haglund S
    Haematol Blood Transfus; 1977; 20():147-56. PubMed ID: 273002
    [No Abstract]   [Full Text] [Related]  

  • 14. Toll-like receptors in lymphoid malignancies: double-edged sword.
    Harsini S; Beigy M; Akhavan-Sabbagh M; Rezaei N
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):262-83. PubMed ID: 24051205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic definition of lymphocytes: functions and markers.
    Stathopoulos G; Davies AJ
    Recent Results Cancer Res; 1976; (56):17-23. PubMed ID: 1087443
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
    Mathé G; Belpomme D; Dantchev D; Pouillart P
    Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte surface markers.
    Thomson AW
    Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100
    [No Abstract]   [Full Text] [Related]  

  • 18. An immunological classification of leukemias and hematosarcomas based on cell membrane markers with special reference to null cell disorders.
    Belpomme D; Lelarge N; Feuilhade de Chauvin F; Joseph R; Mathé G
    Recent Results Cancer Res; 1976; (56):98-110. PubMed ID: 1087447
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing.
    Wren D; Walker BA; Brüggemann M; Catherwood MA; Pott C; Stamatopoulos K; Langerak AW; Gonzalez D;
    Haematologica; 2017 Feb; 102(2):e57-e60. PubMed ID: 27846615
    [No Abstract]   [Full Text] [Related]  

  • 20. Volume regulation in leukemic and lymphoma cells in children and determination of cell lineage.
    Yumura K; Kawa-Ha K; Hara J; Franco EP; Ishihara S; Doi S; Yabuuchi H
    Jpn J Cancer Res; 1986 Apr; 77(4):392-8. PubMed ID: 3084429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.